These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 31010144)
1. A Water-Soluble Microencapsulated Milk Thistle Extract as Active Ingredient for Dermal Formulations. Esposito T; Sansone F; Russo P; Picerno P; Aquino RP; Gasparri F; Mencherini T Molecules; 2019 Apr; 24(8):. PubMed ID: 31010144 [TBL] [Abstract][Full Text] [Related]
2. Application of Spray Drying Particle Engineering to a High-Functionality/Low-Solubility Milk Thistle Extract: Powders Production and Characterization. Sansone F; Esposito T; Lauro MR; Picerno P; Mencherini T; Gasparri F; De Santis S; Chieppa M; Cirillo C; Aquino RP Molecules; 2018 Jul; 23(7):. PubMed ID: 30011893 [TBL] [Abstract][Full Text] [Related]
3. A new approach to enhance oral bioavailability of Silybum Marianum dry extract: association of mechanochemical activation and spray congealing. Passerini N; Perissutti B; Albertini B; Franceschinis E; Lenaz D; Hasa D; Locatelli I; Voinovich D Phytomedicine; 2012 Jan; 19(2):160-8. PubMed ID: 21802925 [TBL] [Abstract][Full Text] [Related]
4. Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells. Cufí S; Bonavia R; Vazquez-Martin A; Corominas-Faja B; Oliveras-Ferraros C; Cuyàs E; Martin-Castillo B; Barrajón-Catalán E; Visa J; Segura-Carretero A; Bosch-Barrera J; Joven J; Micol V; Menendez JA Food Chem Toxicol; 2013 Oct; 60():360-8. PubMed ID: 23916468 [TBL] [Abstract][Full Text] [Related]
5. Antiosteoclastic activity of milk thistle extract after ovariectomy to suppress estrogen deficiency-induced osteoporosis. Kim JL; Kim YH; Kang MK; Gong JH; Han SJ; Kang YH Biomed Res Int; 2013; 2013():919374. PubMed ID: 23781510 [TBL] [Abstract][Full Text] [Related]
6. Combinations of grape seed procyanidin extract and milk thistle silymarin extract against lung cancer - The role of MiR-663a and FHIT. Mao JT; Xue B; Lu QY; Lundmark L; Burns W; Yang J; Lee RP; Glass J; Qualls C; Massie L Life Sci; 2023 Apr; 318():121492. PubMed ID: 36775115 [TBL] [Abstract][Full Text] [Related]
7. Improving the water solubility and antimicrobial activity of silymarin by nanoencapsulation. Lee JS; Hong DY; Kim ES; Lee HG Colloids Surf B Biointerfaces; 2017 Jun; 154():171-177. PubMed ID: 28340483 [TBL] [Abstract][Full Text] [Related]
9. Formulation of microemulsion systems for dermal delivery of silymarin. Panapisal V; Charoensri S; Tantituvanont A AAPS PharmSciTech; 2012 Jun; 13(2):389-99. PubMed ID: 22350738 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract. Wen Z; Dumas TE; Schrieber SJ; Hawke RL; Fried MW; Smith PC Drug Metab Dispos; 2008 Jan; 36(1):65-72. PubMed ID: 17913795 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the effect of hydroxypropyl-β-cyclodextrin on topical administration of milk thistle extract. Spada G; Gavini E; Cossu M; Rassu G; Carta A; Giunchedi P Carbohydr Polym; 2013 Jan; 92(1):40-7. PubMed ID: 23218263 [TBL] [Abstract][Full Text] [Related]
12. Hydrogel-thickened nanoemulsions based on essential oils for topical delivery of psoralen: Permeation and stability studies. Barradas TN; Senna JP; Cardoso SA; Nicoli S; Padula C; Santi P; Rossi F; de Holanda E Silva KG; Mansur CRE Eur J Pharm Biopharm; 2017 Jul; 116():38-50. PubMed ID: 27867112 [TBL] [Abstract][Full Text] [Related]
13. Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)-Chemistry, Bioavailability, and Metabolism. Bijak M Molecules; 2017 Nov; 22(11):. PubMed ID: 29125572 [TBL] [Abstract][Full Text] [Related]
14. Poor chemical and microbiological quality of the commercial milk thistle-based dietary supplements may account for their reported unsatisfactory and non-reproducible clinical outcomes. Fenclova M; Novakova A; Viktorova J; Jonatova P; Dzuman Z; Ruml T; Kren V; Hajslova J; Vitek L; Stranska-Zachariasova M Sci Rep; 2019 Jul; 9(1):11118. PubMed ID: 31366891 [TBL] [Abstract][Full Text] [Related]
15. Formulation and clinical evaluation of silymarin pluronic-lecithin organogels for treatment of atopic dermatitis. Mady FM; Essa H; El-Ammawi T; Abdelkader H; Hussein AK Drug Des Devel Ther; 2016; 10():1101-10. PubMed ID: 27022248 [TBL] [Abstract][Full Text] [Related]
16. Neural Network-based Optimization of Hanafi A; Safa KD; Rezazadeh S Curr Comput Aided Drug Des; 2023; 19(1):2-12. PubMed ID: 36221887 [TBL] [Abstract][Full Text] [Related]
17. Silymarin-loaded solid nanoparticles provide excellent hepatic protection: physicochemical characterization and in vivo evaluation. Yang KY; Hwang du H; Yousaf AM; Kim DW; Shin YJ; Bae ON; Kim YI; Kim JO; Yong CS; Choi HG Int J Nanomedicine; 2013; 8():3333-43. PubMed ID: 24039417 [TBL] [Abstract][Full Text] [Related]
18. Recent advances in the analysis of flavonolignans of Silybum marianum. Csupor D; Csorba A; Hohmann J J Pharm Biomed Anal; 2016 Oct; 130():301-317. PubMed ID: 27321822 [TBL] [Abstract][Full Text] [Related]
19. Antioxidant and hepatoprotective effects of silymarin phytosomes compared to milk thistle extract in CCl4 induced hepatotoxicity in rats. El-Gazayerly ON; Makhlouf AI; Soelm AM; Mohmoud MA J Microencapsul; 2014; 31(1):23-30. PubMed ID: 23808477 [TBL] [Abstract][Full Text] [Related]
20. Milk thistle (Silybum marianum (L.)Gaertn.): An overview about its pharmacology and medicinal uses with an emphasis on oral diseases. Eita AAB J Oral Biosci; 2022 Mar; 64(1):71-76. PubMed ID: 34968721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]